Literature DB >> 12934195

Mannose-binding lectin polymorphisms in clinical tuberculosis.

Christian Søborg1, Hans O Madsen, Ase B Andersen, Troels Lillebaek, Axel Kok-Jensen, Peter Garred.   

Abstract

Mannose-binding lectin (MBL) mediates protection against infections by using the complement system, but certain microorganisms may increase infectivity by exploiting this host defense system. Thus, it has been speculated whether genetically determined low MBL levels may confer partial protection against certain intracellular microorganisms, such as Mycobacterium tuberculosis. We investigated MBL alleles in 109 culture-positive human immunodeficiency virus-uninfected patients with tuberculosis living in Denmark and 250 white control subjects. Patients and control subjects were divided into 3 different groups defined by undetectable, low, and high serum MBL concentrations, which correlates to deficient, low, and high expressing MBL genotypes. A significantly decreased frequency of patients with the low-expressing MBL genotype was observed in white patients compared to control subjects. The same tendency also was observed in patients of other ethnic origin. It may be hypothesized that heterozygosity for MBL variant alleles, which encodes low serum MBL levels, is associated with protection against clinical tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934195     DOI: 10.1086/377183

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  56 in total

1.  Gene-gene interaction between tuberculosis candidate genes in a South African population.

Authors:  Erika de Wit; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Mamm Genome       Date:  2010-08-27       Impact factor: 2.957

2.  Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection.

Authors:  V Khajoee; M Saito; H Takada; A Nomura; K Kusuhara; S-I Yoshida; Y Yoshikai; T Hara
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Lung infections and innate host defense.

Authors:  Ma Valdivia-Arenas; A Amer; Ln Henning; Md Wewers; Ls Schlesinger
Journal:  Drug Discov Today Dis Mech       Date:  2007

4.  An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3' haplotypes could modify circulating levels of mannose-binding lectin.

Authors:  Toralf Bernig; Willemijn Breunis; Nannette Brouwer; Amy Hutchinson; Robert Welch; Dirk Roos; Taco Kuijpers; Stephen Chanock
Journal:  Hum Genet       Date:  2005-10-06       Impact factor: 4.132

5.  Is there a role for mannan-binding lectin in the diagnosis of inflammatory bowel disease?

Authors:  Christina Hoffmann; Peter Hoffmann; Andreas Lun; Carsten Büning; Falk Hiepe; Hans U Scherer; Elisabeth Steinhagen-Thiessen; Andreas Weimann
Journal:  Immunogenetics       Date:  2010-02-25       Impact factor: 2.846

6.  Mannose binding lectin genotypes influence recovery from hepatitis B virus infection.

Authors:  Chloe L Thio; Timothy Mosbruger; Jacquie Astemborski; Spencer Greer; Gregory D Kirk; Stephen J O'Brien; David L Thomas
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis.

Authors:  James D Chalmers; Misao Matsushita; David C Kilpatrick; Adam T Hill
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 8.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

9.  Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis.

Authors:  Alison A Motsinger-Reif; Paulo R Z Antas; Noffisat O Oki; Shawn Levy; Steven M Holland; Timothy R Sterling
Journal:  BMC Med Genet       Date:  2010-03-02       Impact factor: 2.103

Review 10.  C-type lectin receptors in tuberculosis: what we know.

Authors:  Surabhi Goyal; Tilman E Klassert; Hortense Slevogt
Journal:  Med Microbiol Immunol       Date:  2016-07-28       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.